iANTHUS CAPITAL HOLDINGS (ITHUF) Goodwill & Intangibles (2020 - 2026)
iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Goodwill & Intangibles came in at $66.8 million in Q1 2026, down 13.15% year-on-year from $76.9 million in Q1 2025, and down 3.25% quarter-over-quarter from $69.0 million in Q4 2025.
iANTHUS CAPITAL HOLDINGS (ITHUF) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
iANTHUS CAPITAL HOLDINGS has disclosed Goodwill & Intangibles across 7 years of filings, most recently posting $66.8 million for Q1 2026.
- Goodwill & Intangibles for Q1 2026 came in at $66.8 million, down 13.15% year-over-year; the trailing twelve-month figure through Mar 2026 was $66.8 million (down 13.15% YoY), and the FY2025 annual result was $69.0 million, down 12.63% from the prior year.
- Goodwill & Intangibles came in at $66.8 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $69.0 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $154.1 million in Q1 2022 to a low of $66.8 million in Q1 2026.
- The 5-year median for Goodwill & Intangibles is $101.9 million (2024), against an average of $102.4 million.
- Across the five-year window, Goodwill & Intangibles dropped 0.44% in 2022 and decreased 26.44% in 2023, its largest moves.
- iANTHUS CAPITAL HOLDINGS's Goodwill & Intangibles stood at $117.0 million in 2022, then retreated by 9.97% to $105.4 million in 2023, then declined by 25.02% to $79.0 million in 2024, then fell by 12.63% to $69.0 million in 2025, then retreated by 3.25% to $66.8 million in 2026.
- The last three Goodwill & Intangibles figures came in at $66.8 million (Q1 2026), $69.0 million (Q4 2025), and $72.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | iANTHUS CAPITAL HOLDINGS | - | - | 15.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 66.79 Mn |
| Dec 31, 2025 | 69.03 Mn |
| Sep 30, 2025 | 72.41 Mn |
| Jun 30, 2025 | 74.63 Mn |
| Mar 31, 2025 | 76.91 Mn |
| Dec 31, 2024 | 79.01 Mn |
| Sep 30, 2024 | 94.75 Mn |
| Jun 30, 2024 | 98.46 Mn |
| Mar 31, 2024 | 101.90 Mn |
| Dec 31, 2023 | 105.37 Mn |
| Sep 30, 2023 | 108.79 Mn |
| Jun 30, 2023 | 112.25 Mn |
| Mar 31, 2023 | 113.39 Mn |
| Dec 31, 2022 | 117.05 Mn |
| Sep 30, 2022 | 145.96 Mn |
| Jun 30, 2022 | 150.03 Mn |
| Mar 31, 2022 | 154.14 Mn |
| Dec 31, 2021 | 139.06 Mn |
| Sep 30, 2021 | 147.57 Mn |
| Jun 30, 2021 | 150.99 Mn |